Global High Intensity Focused Ultrasound (HIFU) Market Report 2024: Market to Grow by $78.6 Billion to 2030 - This Modern-day Scientific Approach Gaining Prominence for its Non-invasive Method

News provided by

Feb 16, 2024, 13:45 ET

DUBLIN, Feb. 16, 2024 /PRNewswire/ -- The "Global High Intensity Focused Ultrasound (HIFU) Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

The High-intensity targeted ultrasound therapy market is anticipated to be worth around US$194.18 Million by 2030 from US$115.55 Million in 2023, growing at a CAGR of 7.70% from 2024 to 2030

High-Intensity Focused Ultrasound (HIFU) therapy is a modern-day scientific approach gaining prominence for its non-invasive method. HIFU objectives specific tissues with the aid of using particular ultrasound waves, generating heat for therapeutic applications without damaging surrounding areas.

Widely used for situations like prostate cancer and uterine fibroids, HIFU minimizes healing instances and side effects compared to standard medications. Its reputation stems from its precision, decreased invasiveness, and capability programs in various medical fields. As demand for non-surgical interventions rises, HIFU emerges as a transformative technology, using advancements within the clinical panorama with its effectiveness and minimum impact on patients.

Cancer rates are disproportionately excessive in developing nations, affecting about One in Three people all through their lifetime, as per the Global Burden of Diseases (GBD). Uterine fibroids, 77% of ladies of age 50, contribute notably to global healthcare demanding challenges, with an expected 226.05 Million cases. The growing elderly populace and the surge in chronic diseases are escalating global healthcare expenditure.

High-Intensity Focused Ultrasound (HIFU) is an attractive response for healthcare companies and payers, offering cost effectiveness and minimally invasive interventions. The increasing cognizance of HIFU's benefits, supported by mounting scientific proof, drives increasing demand among patients and healthcare professionals, propelling the HIFU therapy market increase.

Further, High-depth, focused ultrasound stands at the forefront of clinical innovation, poised to transform disease treatment tactics. Precisely concentrating on particular tissues with high-frequency sound waves, HIFU provides a minimally invasive and regularly curative opportunity to conventional surgery and radiation therapy. Technological strides propel the sector's increase, providing real-time imaging improvements, robot structures improving targeting accuracy, and modern transducer designs allowing deeper tissue penetration.

Advanced software programs aid treatment planning, while A.I. explores customized optimization. Expanding beyond cancer, HIFU shows promise in diverse applications sponsored by developing clinical evidence. Emerging trends include closed-loop structures, combination therapies, and the potential miniaturization of gadgets, positioning HIFU as a mainstream healing alternative with ongoing interesting innovations for advanced patient care and results.

Besides, regulatory approvals are pivotal for HIFU technology, boosting credibility and spurring investor confidence, prompting improved investment in research, improvement, and commercialization. Beyond confidence-building, approvals broaden HIFU's market reach by endorsing new applications, tapping into untapped patient populations, diversifying treatments, and adding revenue streams.

Examples encompass U.S. Food and Drug Administration (FDA) approvals for chronic tremor, prostate cancer, uterine fibroids, and persistent pain, European Medicines Agency (EMA) acclaim for uterine fibroids, and Chinese Food and Drug Administration (CFDA) approval for liver cancer, pancreatic cancer, and bone tumors. The HIFU market's expansion into aesthetic applications, like skin tightening and fat removal, similarly propels usual growth.

In the dynamic realm of medical technology, HIFU (high-depth targeted ultrasound) therapy, particularly the MRI HIFU variant, is gaining prominence

The high-intensity focused ultrasound therapy market is divided into ultrasound HIFU therapy and MRI HIFU therapy by imaging technology. This innovative technique seamlessly integrates MRI steering into the HIFU process, driving a sizeable increase in the global HIFU market. Studies indicate advanced success rates and lower headaches for MRI HIFU, especially in complicated cases, preserving its minimally invasive nature and lowering restoration times and hospitalization rates. Its precision expands applications across numerous conditions like prostate cancer, liver tumors, uterine fibroids, and critical tremors.

Continuous technological improvements in MRI and HIFU transducers shape the market's trajectory, enhancing accuracy and efficacy. Mounting clinical evidence supports the protection and effectiveness of MRI HIFU, fostering wider adoption by healthcare providers. Increased focus has precipitated heightened funding, contributing to the ongoing growth and promising future outlook of the MRI HIFU market.

Prostate cancer stands as a formidable force in medical innovation, asserting itself as the HIFU (high-intensity focused ultrasound) leader

By application, the High-Intensity Focused Ultrasound Therapy Market is fragmented into Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others. Prostate cancer, the most common cancer globally, drives the demand for HIFU (high-depth focused ultrasound) due to its minimally invasive technique, proven efficacy in early-level cases, and non-surgical benefits for faster healing. HIFU's non-surgical benefits, which include more rapid healing and minimal blood loss, appeal to those seeking minimum invasive options. Its versatility in preliminary remedy, salvage therapy, and palliation widens its utility.

Technological improvements, especially in real-time imaging and energy delivery, enhance accuracy, efficacy, and safety, ensuring HIFU stays competitive. Increasing attention amongst patients and healthcare professionals drives market demand, while a supportive regulatory environment, spotting HIFU's potential and approving new applications, propels expansion and fosters innovation.

Hospitals wield significant influence in the global HIFU (high-intensity focused ultrasound) market, serving as pivotal hubs for effective HIFU system operation

By end-user, the High-Intensity Focused Ultrasound Therapy Market is broken up into Diagnostic Centers, Hospitals, Research Centers, and Others. Hospitals seamlessly combine HIFU into their medical specialties, consisting of urology, oncology, and pain control, possessing dedicated remedy facilities, trained employees, superior imaging, and sturdy infrastructure.

Hospitals channel patients to HIFU remedies as referral centers, creating a captive audience. Their monetary assets permit full-size investments in HIFU devices, ensuring consistent access. Leading hospitals actively contribute to HIFU research, fostering innovation and improving therapy protocols. Also, their regulatory compliance, protection protocols, and role in compensation negotiations solidify their dominance in steering the global HIFU market.

U.S. leads HIFU technology improvement, pushed by top research institutions and clinical tool corporations, fostering a competitive edge

Early contributions and ongoing improvements bolster U.S. producers, with the FDA's sturdy regulatory framework instilling self-assurance and promoting widespread HIFU adoption in the healthcare system. High U.S. healthcare rates facilitate the speedy adoption of modern-day technologies by hospitals. The state's vital research and improved infrastructure drives HIFU innovation, attracting investment and talent.

Aligned with the healthcare system's preference for minimally invasive methods, HIFU's non-surgical technique fits situations like prostate cancer and uterine fibroids. Growing public focus, fuelled by media and advocacy, propels HIFU demand, encouraging healthcare companies to combine it prominently. The favorable repayment panorama incentivizes hospitals and vendors to embody HIFU readily.

Company Analysis: Overview, Recent Developments, Revenue

Koninklijke Philips N.V.
Johnson & Johnson
Hitachi Ltd.
General Electrics
Medtronic Plc.
Stryker
EDAP TMS S.A
Theraclion

Imaging Technology - High Intensity Focused Ultrasound Therapy Market breakup from 2 viewpoints:

Ultrasound HIFU Therapy
MRI HIFU Therapy

Application - High Intensity Focused Ultrasound Therapy Market breakup from 5 viewpoints:

Prostate Cancer
Uterine Fibroids
Neurological Disorders
Aesthetics
Others

End-User - High Intensity Focused Ultrasound Therapy Market breakup from 4 viewpoints:

Diagnostic Centers
Hospitals
Research Centers
Others

Country - Breakup from 26 Country High Intensity Focused Ultrasound Therapy Market:

North America

United States
Canada

Europe

France
Germany
Italy
Spain
United Kingdom
Belgium
Netherlands
Turkey
Asia - Pacific
China
Japan
India
South Korea
Thailand
Malaysia
Indonesia
Australia
New Zealand

Latin America

Brazil
Mexico
Argentina

Middle East & Africa

Saudi Arabia
UAE
South Africa

Rest of the World

For more information about this report visit https://www.researchandmarkets.com/r/o7ge9b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets